Correlation Between Neurobo Pharmaceuticals and Virpax Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurobo Pharmaceuticals and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Virpax Pharmaceuticals.

Diversification Opportunities for Neurobo Pharmaceuticals and Virpax Pharmaceuticals

0.69

Correlation Coefficient

Neurobo Pharmaceuticals  Virpax Pharmaceuticals

Poor diversification

The 3 months correlation between Neurobo and Virpax is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Virpax Pharmaceuticals go up and down completely randomly.

Pair Corralation between Neurobo Pharmaceuticals and Virpax Pharmaceuticals

Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 0.58 times more return on investment than Virpax Pharmaceuticals. However, Neurobo Pharmaceuticals is 1.72 times less risky than Virpax Pharmaceuticals. It trades about -0.13 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest  344.00  in Neurobo Pharmaceuticals on September 14, 2024 and sell it today you would lose (118.00) from holding Neurobo Pharmaceuticals or give up 34.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.41%
Values	Daily Returns

Neurobo Pharmaceuticals  vs.  Virpax Pharmaceuticals

Neurobo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurobo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Virpax Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Virpax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Neurobo Pharmaceuticals and Virpax Pharmaceuticals

The main advantage of trading using opposite Neurobo Pharmaceuticals and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.

The idea behind Neurobo Pharmaceuticals and Virpax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.